Enteroviruses are small, contagious single-stranded ribonucleic acid (RNA) viruses associated with several human and mammalian diseases. The enterovirus genus comprise 12 species which includes four major serotypes including poliovirus, coxsackievirus, echovirus and enterovirus. The newly identified enteroviruses are named with a system of consecutive numbers as EV68, EV69, EV70, etc. Enteroviruses are among the most common human viruses, infecting approximately one billion people annually, majorly infants and children. Diseases such as polio, meningitis, pancreatitis, hepatitis, encephalitis, hand, foot and mouth disease; birth defects, attention deficit hyperactivity disorder and cardiac disorders are caused by different types of enteroviruses.
These viruses are directly or indirectly transferred from person to person typically by the fecal-oral route, respiratory route and also from the mother to infant in the peripartum period. However, more than 50% of enterovirus infections are asymptomatic. Mild symptoms such as cold and fever occur in the infected person. Therefore, diagnosis of this infection is difficult and would be made easy with technological advancement in diagnostic tools.
Based on the type of diagnostic tests, the enterovirus diagnostic market is analyzed into viral isolation testing, serology testing and polymerase chain reaction (PCR) assay. Viral isolation method is the standard diagnostic method performed by isolating virus from the CSF, blood or feces or from multiple sites. PCR, on the other hand, is a very sensitive and specific diagnostic test method providing rapid test results. In addition, based on the site of diagnosis, the enterovirus diagnostic market is analyzed into four categories as hospitals, commercial or private laboratories, public health laboratories and physician offices. There has been rising number of private clinical laboratories which is taking away the market share of public health laboratories. Public health laboratories are usually the preferred testing sites for endemic infections.
Some of the growth drivers of this market include rising population, lack of vaccination in some low and middle income countries and malnutrition, deteriorating the immune system and activating the enterovirus present in the human body.
Key players in the global enterovirus diagnostic market include Merck Millipore, Quidel Corporation, Norgen Biotek Corp., Quest Diagnostics, BioMerieux, Cepheid, Thermo Fisher Scientific Inc., Alere, Inc. and Abbott Laboratories Ltd.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.